-
Jan 04, 2026Uric Acid Metabolism in Humans Vs Monkeys: Translational Implications For Dru...Explore the evolutionary and metabolic differences in uric acid handling between humans and non-human primates, and how these differences impact translational drug development a... -
Dec 26, 2025Non-Human Primate MASH-Associated Liver Fibrosis Model | Prisys BiotechPrisys Biotech offers a controlled cynomolgus monkey MASH-associated liver fibrosis model for translational antifibrotic drug research, integrating metabolic relevance, quantita... -
Dec 23, 2025Why IMRI-Guided Brain Drug Delivery Is Essential For Precise Targeting in NHP...Learn why iMRI-guided brain drug delivery combined with CED is critical for accurate targeting of small nuclei such as the substantia nigra in NHP studies. Discover how ClearPoi... -
Dec 18, 2025AI-Driven Markerless NHP 3D Behavioral Analysis System | Prisys BiotechDiscover Prisys Biotech's advanced markerless 3D behavioral analysis system for Non-Human Primates (NHP). transforming neuroscientific research with AI-driven, objective, and hi... -
Dec 16, 2025LPS-Induced Acute Lung Inflammation (ALI) NHP Model | Prisys BiotechPrisys Biotech offers a translational LPS-induced Acute Lung Inflammation (ALI) model in cynomolgus monkeys, integrating bronchoscopic induction, CT-guided dose control, BALF an... -
Dec 12, 2025HDM+SEB-Induced Atopic Dermatitis (AtD) Model in Cynomolgus MonkeysDiscover Prisys Biotechnologies’ HDM+SEB-induced atopic dermatitis (AtD) model in cynomolgus monkeys. This clinically relevant NHP model replicates allergen-driven skin inflamma... -
Dec 08, 2025One- To Multi-Compartment PK Models Explained | NHP Pharmacokinetics | Prisys...A clear explanation of one-, two-, and three-compartment pharmacokinetic models and how they guide NHP drug development. Learn how Prisys Biotech supports PK modeling with high-... -
Dec 04, 2025How To Choose A Reliable Preclinical CRO | Key Criteria For Biotech Companies...Learn the essential factors Biotech companies must evaluate when selecting a preclinical CRO. Understand the importance of validated NHP models, advanced facilities, and transla... -
Dec 01, 2025Translational CAR-T Evaluation: In Vitro Expertise & NHP Study Support — Pris...Prisys Biotech provides in vitro CAR-T characterisation, translational biomarker design and NHP study support to de-risk clinical translation with GLP-ready assays. -
Nov 28, 2025Why Do More Than 90% Of CNS Drug Candidates Fail in Clinical Trials?Explore the scientific reasons behind the >90% failure rate of CNS drug candidates and learn why nonhuman primate models offer superior translational value for Alzheimer’s, Park... -
Nov 24, 2025Parkinson’s Disease Preclinical Models: A Guide To Selecting Neurotoxin, Gene...Learn how to select the most appropriate preclinical model for Parkinson’s disease drug and cell therapy development. This guide compares MPTP and 6-OHDA models, highlights gene... -
Nov 21, 2025High-Precision Drug Delivery And AI-Driven NHP Translational PlatformsPrisys Biotech provides AAALAC-accredited NHP translational research services with advanced technologies including RT-iMRI-guided CNS delivery, AI-driven 3D behavioral analysis,...
